1. Cassetta, Luca, Fragkogianni, Stamatina, Sims, Andrew H, Smith, Harriet O, Pollard, Jeffrey W. 2019. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. In Cancer cell, 35, 588-602.e10. doi:10.1016/j.ccell.2019.02.009. https://pubmed.ncbi.nlm.nih.gov/30930117/
2. Li, Sensen, Jiang, Longfeng, Yang, Yanbing, Deng, Xiaozhao, Li, Yaojun. 2020. Siglec1 enhances inflammation through miR-1260-dependent degradation of IκBα in COPD. In Experimental and molecular pathology, 113, 104398. doi:10.1016/j.yexmp.2020.104398. https://pubmed.ncbi.nlm.nih.gov/32007531/
3. Graf, Manuel, von Stuckrad, Sae Lim, Uruha, Akinori, Schneider, Udo, Rose, Thomas. . SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies. In RMD open, 8, . doi:10.1136/rmdopen-2021-001934. https://pubmed.ncbi.nlm.nih.gov/35177553/
4. Singh, Rohit, Choi, Beom K. 2019. Siglec1-expressing subcapsular sinus macrophages provide soil for melanoma lymph node metastasis. In eLife, 8, . doi:10.7554/eLife.48916. https://pubmed.ncbi.nlm.nih.gov/31872800/
5. Prather, Randall S, Rowland, Raymond R R, Ewen, Catherine, Egen, Tina, Green, Jonathan A. 2013. An intact sialoadhesin (Sn/SIGLEC1/CD169) is not required for attachment/internalization of the porcine reproductive and respiratory syndrome virus. In Journal of virology, 87, 9538-46. doi:10.1128/JVI.00177-13. https://pubmed.ncbi.nlm.nih.gov/23785195/